Subcellular Localization and Quantification of Androgen Receptor in Hormone-Naive Prostatic Adenocarcinoma and Clinical Correlation

被引：0
|
作者：
Huang, W.
Hoyt, C.
Pier, T.
Fletcher-Holmes, D.
机构：
[1] Univ Wisconsin Madison, Madison, WI USA
[2] Cambridge Res & Instrumentat Inc, Woburn, MA USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
838
引用
收藏
页码：199A / 199A
页数：1
相关论文
共 50 条
  • [1] Subcellular Localization and Quantification of Androgen Receptor in Hormone-Naive Prostatic Adenocarcinoma and Clinical Correlation
    Huang, W.
    Hoyt, C.
    Pier, T.
    Fletcher-Holmes, D.
    MODERN PATHOLOGY, 2011, 24 : 199A - 199A
  • [2] Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer
    S Merson
    Z H Yang
    D Brewer
    D Olmos
    A Eichholz
    F McCarthy
    G Fisher
    G Kovacs
    D M Berney
    C S Foster
    H Møller
    P Scardino
    J Cuzick
    C S Cooper
    J P Clark
    British Journal of Cancer, 2014, 110 : 1655 - 1662
  • [3] Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer
    Merson, S.
    Yang, Z. H.
    Brewer, D.
    Olmos, D.
    Eichholz, A.
    McCarthy, F.
    Fisher, G.
    Kovacs, G.
    Berney, D. M.
    Foster, C. S.
    Moller, H.
    Scardino, P.
    Cuzick, J.
    Cooper, C. S.
    Clark, J. P.
    BRITISH JOURNAL OF CANCER, 2014, 110 (06) : 1655 - 1662
  • [4] APPLICABILITY OF NUCLEAR ANDROGEN RECEPTOR QUANTIFICATION TO HUMAN PROSTATIC ADENOCARCINOMA
    FENTIE, DD
    LAKEY, WH
    MCBLAIN, WA
    JOURNAL OF UROLOGY, 1986, 135 (01): : 167 - 173
  • [5] Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration-resistant disease
    Zellweger, Tobias
    Stuerm, Susanne
    Rey, Silvia
    Zlobec, Inti
    Gsponer, Joel R.
    Rentsch, Cyrill A.
    Terracciano, Luigi M.
    Bachmann, Alexander
    Bubendorf, Lukas
    Ruiz, Christian
    ENDOCRINE-RELATED CANCER, 2013, 20 (03) : 403 - 413
  • [6] EXPRESSION AND LOCALIZATION OF ANDROGEN RECEPTOR IN THE R-3327 DUNNING RAT PROSTATIC ADENOCARCINOMA
    QUARMBY, VE
    BECKMAN, WC
    COOKE, DB
    LUBAHN, DB
    JOSEPH, DR
    WILSON, EM
    FRENCH, FS
    CANCER RESEARCH, 1990, 50 (03) : 735 - 739
  • [7] Phase II Clinical Trial of GM-CSF Treatment in Patients with Hormone-Refractory or Hormone-Naive Adenocarcinoma of the Prostate
    Amato, Robert J.
    Hernandez-McClain, Joan
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2008, 2 : 471 - 475
  • [8] Nuclear factor κB predicts poor outcome in patients with hormone-naive prostate cancer with high nuclear androgen receptor
    MacKenzie, Lewis
    McCall, Pamela
    Hatziieremia, Sophia
    Catlow, Jamie
    Adams, Claire
    McArdle, Peter
    Seywright, Morag
    Tanahill, Claire
    Paul, Andrew
    Underwood, Mark
    MacKay, Simon
    Plevin, Robin
    Edwards, Joanne
    HUMAN PATHOLOGY, 2012, 43 (09) : 1491 - 1500
  • [9] A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naive Metastatic Prostate Cancer
    Corn, Paul G.
    Zhang, Miao
    Nogueras-Gonzalez, Graciela M.
    Xiao, Lianchun
    Zurita, Amado J.
    Subudhi, Sumit K.
    Tu, Shi-Ming
    Aparicio, Ana M.
    Coarfa, Cristian
    Rajapakshe, Kimal
    Huang, Shixia
    Navone, Nora M.
    Lin, Sue-Hwa
    Wang, Guocan
    Ramachandran, Sumankalai
    Titus, Mark A.
    Panaretakis, Theocharis
    Gallick, Gary E.
    Efstathiou, Eleni
    Troncoso, Patricia
    Logothetis, Christopher
    CLINICAL CANCER RESEARCH, 2020, 26 (05) : 990 - 999
  • [10] Androgen Receptor Phosphorylation is Associated With Clinical Outcome Measures in Hormone Naive Prostate Cancer
    McCall, P.
    Willder, J. M.
    Heng, S. J.
    Tannahill, C.
    Orange, C.
    Seywright, M.
    Underwood, M. A.
    Edwards, J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S186 - S186
12345